title: Cardiology patient page. Breast cancer chemotherapy and your heart.
authors: From the Cardio-Oncology Program (C.U., K.M., J.M.) and Medical Oncology (S.T., J.M.), Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (J.M.); and Cardio-Oncology Program, Vanderbilt School of Medicine, Nashville, TN (J.M.).
authors: Christine
authors: C
authors: Unitt
authors: From the Cardio-Oncology Program (C.U., K.M., J.M.) and Medical Oncology (S.T., J.M.), Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (J.M.); and Cardio-Oncology Program, Vanderbilt School of Medicine, Nashville, TN (J.M.).
authors: Kamaneh
authors: K
authors: Montazeri
authors: From the Cardio-Oncology Program (C.U., K.M., J.M.) and Medical Oncology (S.T., J.M.), Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (J.M.); and Cardio-Oncology Program, Vanderbilt School of Medicine, Nashville, TN (J.M.).
authors: Sara
authors: S
authors: Tolaney
authors: From the Cardio-Oncology Program (C.U., K.M., J.M.) and Medical Oncology (S.T., J.M.), Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (J.M.); and Cardio-Oncology Program, Vanderbilt School of Medicine, Nashville, TN (J.M.). javid.moslehi@vanderbilt.edu.
authors: Javid
authors: J
authors: Moslehi
mesh_terms: D018943:Anthracyclines / Q000009:adverse effects / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy*; D009202:Cardiomyopathies / Q000453:epidemiology; D004358:Drug Therapy; D005260:Female; D006331:Heart Diseases / Q000453:epidemiology*; D006333:Heart Failure / Q000453:epidemiology; D006801:Humans; D012307:Risk Factors; D000068878:Trastuzumab
chemical_list: D018943:Anthracyclines; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068878:Trastuzumab